MedOrion Enhances Its Behavioral Science Software with New CAHPS Solution

MedOrion’s solution seamlessly combines behavioral science and AI  to uncover members’ psychological motivations, achieving a notable 5% increase in CAHPS GNC and a 26% reduction in complaint rates

LOUISVILLE, Ky., Nov. 14, 2024 /PRNewswire/ — MedOrion, a leading healthcare software company, announces today the release of a new CAHPS solution, expanding its proven behavioral science platform to the member satisfaction domain.
Its innovative Electronic Behavioral Record (EBR) engine has already transformed quality outcomes for leading health plans in the pharmacy and HEDIS spaces. With its new CAHPS solution, MedOrion continues to empower health plans to drive results across multiple-star rating measures, providing a holistic and cost-effective platform.

To celebrate the launch, MedOrion is hosting a free webinar, Unlocking New CAHPS Insights: Fireside Chat with Industry Experts,” on December 4th, 2024, at 11:00 AM EST.
Attendees will gain actionable strategies from a panel of distinguished experts, including David Reid, Senior Director of Medicare Member Experience at Florida Blue; Misty Roberts, VP of Quality & Performance Outcomes at CareSource; and Dr. David B. Nash, Professor of Health Policy at Jefferson College of Population Health. Register here to secure your spot.

CAHPS scores pose a unique challenge for health plans, as they rely on unpredictable member sampling through surveys. MedOrion’s solution leverages its proprietary, scalable, behavioral science engine (EBR) to identify members at risk of low satisfaction scores and to effectively engage and persuade ALL OF THEM to take actions that increase their likelihood of becoming satisfied members.
This unique approach facilitates meaningful interactions even with challenging populations, such as those with Social Risk Factors (SRFs), helping health plans proactively improve the member experience while advancing health equity.

About MedOrion
MedOrion develops a healthcare SaaS solution that helps organizations improve clinical quality and financial outcomes by continually uncovering and addressing members’ psychological barriers to action and automatically persuading them to adhere to medical guidelines.
With over 4 million members managed, MedOrion has consistently delivered impressive results for industry leaders, translating behavioral insights into substantial gains in health outcomes.

Photo – https://healthtechnologynet.com/wp-content/uploads/2024/11/Medorion_Webinar_Invite.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/medorion-enhances-its-behavioral-science-software-with-new-cahps-solution-302305539.html

SOURCE MedOrion

Staff

Recent Posts

NervGen Pharma Announces Proposed Amendment to Warrants

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

5 hours ago

MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 12, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"),…

7 hours ago

Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend

NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce…

7 hours ago

ISHI Health Launches Virtual Heart Failure Clinics in California and Arizona

SAN DIEGO, Dec. 12, 2025 /PRNewswire/ -- ISHI Health, an innovator in AI-enabled virtual cardiac…

7 hours ago

Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care

LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight…

7 hours ago

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP)…

7 hours ago